[
  {
    "ts": "2026-02-03T01:50:55+00:00",
    "headline": "Google, Amazon, Nvidia Lead Earnings Barrage. Here's How To Get Ready.",
    "summary": "Welcome to a revamped How To Invest newsletter as upcoming earnings from Google, Amazon and more bring these rules into focus.",
    "url": "https://www.investors.com/how-to-invest/how-to-invest-google-amazon-nvidia-lead-earnings-barrage-how-to-get-ready/?src=A00220&yptr=yahoo",
    "source": "Investor's Business Daily",
    "provider": "yfinance",
    "raw": {
      "id": "aca8ec15-7d9b-337b-936d-7c0ff1638750",
      "content": {
        "id": "aca8ec15-7d9b-337b-936d-7c0ff1638750",
        "contentType": "STORY",
        "title": "Google, Amazon, Nvidia Lead Earnings Barrage. Here's How To Get Ready.",
        "description": "",
        "summary": "Welcome to a revamped How To Invest newsletter as upcoming earnings from Google, Amazon and more bring these rules into focus.",
        "pubDate": "2026-02-03T01:50:55Z",
        "displayTime": "2026-02-03T01:50:55Z",
        "isHosted": false,
        "bypassModal": false,
        "previewUrl": "https://finance.yahoo.com/m/aca8ec15-7d9b-337b-936d-7c0ff1638750/google-amazon-nvidia-lead.html",
        "thumbnail": {
          "originalUrl": "https://media.zenfs.com/en/ibd.com/13a27f4f97c086470ff38a88cca15646",
          "originalWidth": 1000,
          "originalHeight": 563,
          "caption": "",
          "resolutions": [
            {
              "url": "https://s.yimg.com/uu/api/res/1.2/pY5BjPos4QpHNNfuqfq88g--~B/aD01NjM7dz0xMDAwO2FwcGlkPXl0YWNoeW9u/https://media.zenfs.com/en/ibd.com/13a27f4f97c086470ff38a88cca15646.cf.webp",
              "width": 1000,
              "height": 563,
              "tag": "original"
            },
            {
              "url": "https://s.yimg.com/uu/api/res/1.2/au_4fZO9C1Ru1LJcbrDx8A--~B/Zmk9c3RyaW07aD0xMjg7dz0xNzA7YXBwaWQ9eXRhY2h5b24-/https://media.zenfs.com/en/ibd.com/13a27f4f97c086470ff38a88cca15646.cf.webp",
              "width": 170,
              "height": 128,
              "tag": "170x128"
            }
          ]
        },
        "provider": {
          "displayName": "Investor's Business Daily",
          "url": "http://www.investors.com/"
        },
        "canonicalUrl": {
          "url": "https://www.investors.com/how-to-invest/how-to-invest-google-amazon-nvidia-lead-earnings-barrage-how-to-get-ready/?src=A00220&yptr=yahoo",
          "site": "finance",
          "region": "US",
          "lang": "en-US"
        },
        "clickThroughUrl": null,
        "metadata": {
          "editorsPick": false
        },
        "finance": {
          "stockTickers": [
            {
              "symbol": "GOOG"
            },
            {
              "symbol": "AMZN"
            },
            {
              "symbol": "NVDA"
            },
            {
              "symbol": "AMD"
            },
            {
              "symbol": "LLY"
            },
            {
              "symbol": "NVS"
            }
          ],
          "premiumFinance": {
            "isPremiumNews": false,
            "isPremiumFreeNews": false
          }
        },
        "storyline": null
      }
    }
  },
  {
    "ts": "2026-02-03T00:49:51+00:00",
    "headline": "AbCellera Biologics Inc. (ABCL): A Bull Case Theory",
    "summary": "We came across a bullish thesis on AbCellera Biologics Inc. on topsecretstocks’s Substack. In this article, we will summarize the bulls’ thesis on ABCL. AbCellera Biologics Inc.’s share was trading at $3.6200 as of January 21st. ABCL’s trailing P/E was 19.92 according to Yahoo Finance. AbCellera Biologics Inc. engages in discovering and developing antibody-based medicines for indications with unmet […]",
    "url": "https://finance.yahoo.com/news/abcellera-biologics-inc-abcl-bull-004951347.html",
    "source": "Insider Monkey",
    "provider": "yfinance",
    "raw": {
      "id": "34899ecc-990f-3d20-8fdb-b7459d1de7ab",
      "content": {
        "id": "34899ecc-990f-3d20-8fdb-b7459d1de7ab",
        "contentType": "STORY",
        "title": "AbCellera Biologics Inc. (ABCL): A Bull Case Theory",
        "description": "",
        "summary": "We came across a bullish thesis on AbCellera Biologics Inc. on topsecretstocks’s Substack. In this article, we will summarize the bulls’ thesis on ABCL. AbCellera Biologics Inc.’s share was trading at $3.6200 as of January 21st. ABCL’s trailing P/E was 19.92 according to Yahoo Finance. AbCellera Biologics Inc. engages in discovering and developing antibody-based medicines for indications with unmet […]",
        "pubDate": "2026-02-03T00:49:51Z",
        "displayTime": "2026-02-03T00:49:51Z",
        "isHosted": true,
        "bypassModal": false,
        "previewUrl": null,
        "thumbnail": {
          "originalUrl": "https://media.zenfs.com/en/insidermonkey.com/613180d2fa6faca5ddeea8020aa4e5f6",
          "originalWidth": 1280,
          "originalHeight": 720,
          "caption": "",
          "resolutions": [
            {
              "url": "https://s.yimg.com/uu/api/res/1.2/ukO7Dxu9ji3eC8e4kTYdjg--~B/aD03MjA7dz0xMjgwO2FwcGlkPXl0YWNoeW9u/https://media.zenfs.com/en/insidermonkey.com/613180d2fa6faca5ddeea8020aa4e5f6.cf.webp",
              "width": 1280,
              "height": 720,
              "tag": "original"
            },
            {
              "url": "https://s.yimg.com/uu/api/res/1.2/l4B7vEy.zrw5DqZYHB67PA--~B/Zmk9c3RyaW07aD0xMjg7dz0xNzA7YXBwaWQ9eXRhY2h5b24-/https://media.zenfs.com/en/insidermonkey.com/613180d2fa6faca5ddeea8020aa4e5f6.cf.webp",
              "width": 170,
              "height": 128,
              "tag": "170x128"
            }
          ]
        },
        "provider": {
          "displayName": "Insider Monkey",
          "url": "http://www.insidermonkey.com"
        },
        "canonicalUrl": {
          "url": "https://finance.yahoo.com/news/abcellera-biologics-inc-abcl-bull-004951347.html",
          "site": "finance",
          "region": "US",
          "lang": "en-US"
        },
        "clickThroughUrl": {
          "url": "https://finance.yahoo.com/news/abcellera-biologics-inc-abcl-bull-004951347.html",
          "site": "finance",
          "region": "US",
          "lang": "en-US"
        },
        "metadata": {
          "editorsPick": false
        },
        "finance": {
          "stockTickers": [
            {
              "symbol": "ABCL"
            },
            {
              "symbol": "LLY"
            }
          ],
          "premiumFinance": {
            "isPremiumNews": false,
            "isPremiumFreeNews": false
          }
        },
        "storyline": null
      }
    }
  },
  {
    "ts": "2026-02-03T03:14:59+00:00",
    "headline": "Eli Lilly’s New Weight Loss Plant And What It Might Mean For LLY’s Valuation",
    "summary": "Eli Lilly’s new Pennsylvania build and why it matters for the stock Eli Lilly (LLY) has drawn fresh attention after outlining plans to invest more than US$3.5b in a Pennsylvania facility dedicated to injectable weight loss medicines, including the experimental drug retatrutide. The project sits alongside upbeat analyst commentary on Lilly’s obesity and diabetes portfolio and a closely watched earnings report this week, which together put the company’s weight management franchise and capital...",
    "url": "https://finance.yahoo.com/news/eli-lilly-weight-loss-plant-031459271.html",
    "source": "Simply Wall St.",
    "provider": "yfinance",
    "raw": {
      "id": "db3d6cf8-9627-3605-a5e2-f17c805ae3f1",
      "content": {
        "id": "db3d6cf8-9627-3605-a5e2-f17c805ae3f1",
        "contentType": "STORY",
        "title": "Eli Lilly’s New Weight Loss Plant And What It Might Mean For LLY’s Valuation",
        "description": "",
        "summary": "Eli Lilly’s new Pennsylvania build and why it matters for the stock Eli Lilly (LLY) has drawn fresh attention after outlining plans to invest more than US$3.5b in a Pennsylvania facility dedicated to injectable weight loss medicines, including the experimental drug retatrutide. The project sits alongside upbeat analyst commentary on Lilly’s obesity and diabetes portfolio and a closely watched earnings report this week, which together put the company’s weight management franchise and capital...",
        "pubDate": "2026-02-03T03:14:59Z",
        "displayTime": "2026-02-03T03:14:59Z",
        "isHosted": true,
        "bypassModal": false,
        "previewUrl": null,
        "thumbnail": {
          "originalUrl": "https://media.zenfs.com/en/simply_wall_st__316/5eef176f2a2dc130a63fafe4bd1968dd",
          "originalWidth": 1194,
          "originalHeight": 432,
          "caption": "",
          "resolutions": [
            {
              "url": "https://s.yimg.com/uu/api/res/1.2/uZWvuDuy6_Wr6cKvxAFZcw--~B/aD00MzI7dz0xMTk0O2FwcGlkPXl0YWNoeW9u/https://media.zenfs.com/en/simply_wall_st__316/5eef176f2a2dc130a63fafe4bd1968dd.cf.webp",
              "width": 1194,
              "height": 432,
              "tag": "original"
            },
            {
              "url": "https://s.yimg.com/uu/api/res/1.2/g78F5NO5pySOmBHzFi6.eA--~B/Zmk9c3RyaW07aD0xMjg7dz0xNzA7YXBwaWQ9eXRhY2h5b24-/https://media.zenfs.com/en/simply_wall_st__316/5eef176f2a2dc130a63fafe4bd1968dd.cf.webp",
              "width": 170,
              "height": 128,
              "tag": "170x128"
            }
          ]
        },
        "provider": {
          "displayName": "Simply Wall St.",
          "url": "https://simplywall.st/"
        },
        "canonicalUrl": {
          "url": "https://finance.yahoo.com/news/eli-lilly-weight-loss-plant-031459271.html",
          "site": "finance",
          "region": "US",
          "lang": "en-US"
        },
        "clickThroughUrl": {
          "url": "https://finance.yahoo.com/news/eli-lilly-weight-loss-plant-031459271.html",
          "site": "finance",
          "region": "US",
          "lang": "en-US"
        },
        "metadata": {
          "editorsPick": false
        },
        "finance": {
          "stockTickers": [
            {
              "symbol": "LLY"
            }
          ],
          "premiumFinance": {
            "isPremiumNews": false,
            "isPremiumFreeNews": false
          }
        },
        "storyline": null
      }
    }
  },
  {
    "ts": "2026-02-03T03:13:23+00:00",
    "headline": "Eli Lilly (LLY) Reports Q4: Everything You Need To Know Ahead Of Earnings",
    "summary": "Global pharmaceutical company Eli Lilly (NYSE:LLY) will be reporting earnings this Wednesday before market hours. Here’s what to expect.",
    "url": "https://finance.yahoo.com/news/eli-lilly-lly-reports-q4-031323539.html",
    "source": "StockStory",
    "provider": "yfinance",
    "raw": {
      "id": "a3eae7f1-05cd-3e14-8baa-f9c4eda32e9a",
      "content": {
        "id": "a3eae7f1-05cd-3e14-8baa-f9c4eda32e9a",
        "contentType": "STORY",
        "title": "Eli Lilly (LLY) Reports Q4: Everything You Need To Know Ahead Of Earnings",
        "description": "",
        "summary": "Global pharmaceutical company Eli Lilly (NYSE:LLY) will be reporting earnings this Wednesday before market hours. Here’s what to expect.",
        "pubDate": "2026-02-03T03:13:23Z",
        "displayTime": "2026-02-03T03:13:23Z",
        "isHosted": true,
        "bypassModal": false,
        "previewUrl": null,
        "thumbnail": {
          "originalUrl": "https://media.zenfs.com/en/stockstory_922/2d0b545c448821f8d1ada0dbe955b186",
          "originalWidth": 1400,
          "originalHeight": 700,
          "caption": "LLY Cover Image",
          "resolutions": [
            {
              "url": "https://s.yimg.com/uu/api/res/1.2/y7jUkGcVljBpqcrgSnimZQ--~B/aD03MDA7dz0xNDAwO2FwcGlkPXl0YWNoeW9u/https://media.zenfs.com/en/stockstory_922/2d0b545c448821f8d1ada0dbe955b186.cf.webp",
              "width": 1400,
              "height": 700,
              "tag": "original"
            },
            {
              "url": "https://s.yimg.com/uu/api/res/1.2/fw6rZdJZ6CRFkLxhDmPhew--~B/Zmk9c3RyaW07aD0xMjg7dz0xNzA7YXBwaWQ9eXRhY2h5b24-/https://media.zenfs.com/en/stockstory_922/2d0b545c448821f8d1ada0dbe955b186.cf.webp",
              "width": 170,
              "height": 128,
              "tag": "170x128"
            }
          ]
        },
        "provider": {
          "displayName": "StockStory",
          "url": "https://stockstory.org/"
        },
        "canonicalUrl": {
          "url": "https://finance.yahoo.com/news/eli-lilly-lly-reports-q4-031323539.html",
          "site": "finance",
          "region": "US",
          "lang": "en-US"
        },
        "clickThroughUrl": {
          "url": "https://finance.yahoo.com/news/eli-lilly-lly-reports-q4-031323539.html",
          "site": "finance",
          "region": "US",
          "lang": "en-US"
        },
        "metadata": {
          "editorsPick": false
        },
        "finance": {
          "stockTickers": [
            {
              "symbol": "LLY"
            }
          ],
          "premiumFinance": {
            "isPremiumNews": false,
            "isPremiumFreeNews": false
          }
        },
        "storyline": null
      }
    }
  },
  {
    "ts": "2026-02-03T09:34:12+00:00",
    "headline": "Eli Lilly and Company (LLY) to Invest Over $3.5 Billion in New Manufacturing Facility in Pennsylvania",
    "summary": "Eli Lilly and Company (NYSE:LLY) is one of the best long term low volatility stocks to invest in. Eli Lilly and Company (NYSE:LLY) announced on January 30 significant plans to invest over $3.5 billion in a new manufacturing facility in the Lehigh Valley, Pennsylvania, which would function as the company’s newest injectable medicine and device […]",
    "url": "https://finance.yahoo.com/news/eli-lilly-company-lly-invest-093412903.html",
    "source": "Insider Monkey",
    "provider": "yfinance",
    "raw": {
      "id": "0bddb621-4da4-3c62-b913-291f4414a589",
      "content": {
        "id": "0bddb621-4da4-3c62-b913-291f4414a589",
        "contentType": "STORY",
        "title": "Eli Lilly and Company (LLY) to Invest Over $3.5 Billion in New Manufacturing Facility in Pennsylvania",
        "description": "",
        "summary": "Eli Lilly and Company (NYSE:LLY) is one of the best long term low volatility stocks to invest in. Eli Lilly and Company (NYSE:LLY) announced on January 30 significant plans to invest over $3.5 billion in a new manufacturing facility in the Lehigh Valley, Pennsylvania, which would function as the company’s newest injectable medicine and device […]",
        "pubDate": "2026-02-03T09:34:12Z",
        "displayTime": "2026-02-03T09:34:12Z",
        "isHosted": true,
        "bypassModal": false,
        "previewUrl": null,
        "thumbnail": {
          "originalUrl": "https://media.zenfs.com/en/insidermonkey.com/860932d32d923713fdffa5b1d444d8a3",
          "originalWidth": 1456,
          "originalHeight": 816,
          "caption": "Eli Lilly (LLY) Taps Gene-Editing Technology to Target Hearing Loss, Reuters Reports",
          "resolutions": [
            {
              "url": "https://s.yimg.com/uu/api/res/1.2/6aY42asq7dEA24eM0JX3IQ--~B/aD04MTY7dz0xNDU2O2FwcGlkPXl0YWNoeW9u/https://media.zenfs.com/en/insidermonkey.com/860932d32d923713fdffa5b1d444d8a3.cf.webp",
              "width": 1456,
              "height": 816,
              "tag": "original"
            },
            {
              "url": "https://s.yimg.com/uu/api/res/1.2/8359URliL1_uJRGx4OlSUg--~B/Zmk9c3RyaW07aD0xMjg7dz0xNzA7YXBwaWQ9eXRhY2h5b24-/https://media.zenfs.com/en/insidermonkey.com/860932d32d923713fdffa5b1d444d8a3.cf.webp",
              "width": 170,
              "height": 128,
              "tag": "170x128"
            }
          ]
        },
        "provider": {
          "displayName": "Insider Monkey",
          "url": "http://www.insidermonkey.com"
        },
        "canonicalUrl": {
          "url": "https://finance.yahoo.com/news/eli-lilly-company-lly-invest-093412903.html",
          "site": "finance",
          "region": "US",
          "lang": "en-US"
        },
        "clickThroughUrl": {
          "url": "https://finance.yahoo.com/news/eli-lilly-company-lly-invest-093412903.html",
          "site": "finance",
          "region": "US",
          "lang": "en-US"
        },
        "metadata": {
          "editorsPick": false
        },
        "finance": {
          "stockTickers": [
            {
              "symbol": "LLY"
            }
          ],
          "premiumFinance": {
            "isPremiumNews": false,
            "isPremiumFreeNews": false
          }
        },
        "storyline": null
      }
    }
  },
  {
    "ts": "2026-02-03T08:01:46+00:00",
    "headline": "Big Tech and Pharma Earnings: What to Watch This Week",
    "summary": "Earnings season marches on. Two more Magnificent Seven tech companies—Alphabet and Amazon—will report, following on the heels of disappointing results from Microsoft that helped send software stocks tumbling last week.",
    "url": "https://www.wsj.com/livecoverage/stock-market-today-dow-sp-500-nasdaq-02-03-2026/card/big-tech-and-pharma-earnings-what-to-watch-this-week-GbHxCGzyw4fBM6MvY1Vt?siteid=yhoof2&yptr=yahoo",
    "source": "The Wall Street Journal",
    "provider": "yfinance",
    "raw": {
      "id": "438e74ab-57b8-37a1-bea0-98d968b92710",
      "content": {
        "id": "438e74ab-57b8-37a1-bea0-98d968b92710",
        "contentType": "STORY",
        "title": "Big Tech and Pharma Earnings: What to Watch This Week",
        "description": "",
        "summary": "Earnings season marches on. Two more Magnificent Seven tech companies—Alphabet and Amazon—will report, following on the heels of disappointing results from Microsoft that helped send software stocks tumbling last week.",
        "pubDate": "2026-02-03T08:01:46Z",
        "displayTime": "2026-02-03T08:01:46Z",
        "isHosted": false,
        "bypassModal": false,
        "previewUrl": "https://finance.yahoo.com/m/438e74ab-57b8-37a1-bea0-98d968b92710/big-tech-and-pharma-earnings-.html",
        "thumbnail": {
          "originalUrl": "https://media.zenfs.com/en/wsj.com/e6cec99e9a9c923e176c2b256dd003f8",
          "originalWidth": 1280,
          "originalHeight": 640,
          "caption": "",
          "resolutions": [
            {
              "url": "https://s.yimg.com/uu/api/res/1.2/WrpLbN9EPkBkY5Q7DEqcow--~B/aD02NDA7dz0xMjgwO2FwcGlkPXl0YWNoeW9u/https://media.zenfs.com/en/wsj.com/e6cec99e9a9c923e176c2b256dd003f8.cf.webp",
              "width": 1280,
              "height": 640,
              "tag": "original"
            },
            {
              "url": "https://s.yimg.com/uu/api/res/1.2/6T87T9eSRa4Fs4LKL4AqeA--~B/Zmk9c3RyaW07aD0xMjg7dz0xNzA7YXBwaWQ9eXRhY2h5b24-/https://media.zenfs.com/en/wsj.com/e6cec99e9a9c923e176c2b256dd003f8.cf.webp",
              "width": 170,
              "height": 128,
              "tag": "170x128"
            }
          ]
        },
        "provider": {
          "displayName": "The Wall Street Journal",
          "url": "http://www.wsj.com/"
        },
        "canonicalUrl": {
          "url": "https://www.wsj.com/livecoverage/stock-market-today-dow-sp-500-nasdaq-02-03-2026/card/big-tech-and-pharma-earnings-what-to-watch-this-week-GbHxCGzyw4fBM6MvY1Vt?siteid=yhoof2&yptr=yahoo",
          "site": "finance",
          "region": "US",
          "lang": "en-US"
        },
        "clickThroughUrl": null,
        "metadata": {
          "editorsPick": false
        },
        "finance": {
          "stockTickers": [
            {
              "symbol": "PFE"
            },
            {
              "symbol": "NVO"
            },
            {
              "symbol": "GOOG"
            },
            {
              "symbol": "AMZN"
            },
            {
              "symbol": "MSFT"
            },
            {
              "symbol": "LLY"
            },
            {
              "symbol": "AMD"
            },
            {
              "symbol": "MRK"
            },
            {
              "symbol": "MDLZ"
            },
            {
              "symbol": "ABBV"
            },
            {
              "symbol": "QCOM"
            },
            {
              "symbol": "SAN"
            },
            {
              "symbol": "UBER"
            },
            {
              "symbol": "PEP"
            },
            {
              "symbol": "BSX"
            },
            {
              "symbol": "NVS"
            }
          ],
          "premiumFinance": {
            "isPremiumNews": false,
            "isPremiumFreeNews": false
          }
        },
        "storyline": null
      }
    }
  },
  {
    "ts": "2026-02-03T12:24:08+00:00",
    "headline": "Jim Cramer Says Eli Lilly “Could Announce Some New Data, and That Could Get the Stock Rolling”",
    "summary": "Eli Lilly and Company (NYSE:LLY) is one of the stocks on Jim Cramer’s recent game plan. Cramer highlighted what “drives the stock,” as he remarked: Wednesday morning, Eli Lilly reports. Its earnings haven’t been the propellant here. What drives the stock are new reports on GLP-1 clinical trials. But Lilly could announce some new data, […]",
    "url": "https://finance.yahoo.com/news/jim-cramer-says-eli-lilly-122408617.html",
    "source": "Insider Monkey",
    "provider": "yfinance",
    "raw": {
      "id": "6922dd8f-d0ad-3cb5-9d25-41ce5f7f9c45",
      "content": {
        "id": "6922dd8f-d0ad-3cb5-9d25-41ce5f7f9c45",
        "contentType": "STORY",
        "title": "Jim Cramer Says Eli Lilly “Could Announce Some New Data, and That Could Get the Stock Rolling”",
        "description": "",
        "summary": "Eli Lilly and Company (NYSE:LLY) is one of the stocks on Jim Cramer’s recent game plan. Cramer highlighted what “drives the stock,” as he remarked: Wednesday morning, Eli Lilly reports. Its earnings haven’t been the propellant here. What drives the stock are new reports on GLP-1 clinical trials. But Lilly could announce some new data, […]",
        "pubDate": "2026-02-03T12:24:08Z",
        "displayTime": "2026-02-03T12:24:08Z",
        "isHosted": true,
        "bypassModal": false,
        "previewUrl": null,
        "thumbnail": {
          "originalUrl": "https://media.zenfs.com/en/insidermonkey.com/5f241f83ea3e77a50a204217fc3a84bc",
          "originalWidth": 6000,
          "originalHeight": 4000,
          "caption": "",
          "resolutions": [
            {
              "url": "https://s.yimg.com/uu/api/res/1.2/ZkD7SKPhnV0JAfwbIcdRzw--~B/aD00MDAwO3c9NjAwMDthcHBpZD15dGFjaHlvbg--/https://media.zenfs.com/en/insidermonkey.com/5f241f83ea3e77a50a204217fc3a84bc.cf.webp",
              "width": 6000,
              "height": 4000,
              "tag": "original"
            },
            {
              "url": "https://s.yimg.com/uu/api/res/1.2/L4j5V2E1WUYhhZOm4mup9Q--~B/Zmk9c3RyaW07aD0xMjg7dz0xNzA7YXBwaWQ9eXRhY2h5b24-/https://media.zenfs.com/en/insidermonkey.com/5f241f83ea3e77a50a204217fc3a84bc.cf.webp",
              "width": 170,
              "height": 128,
              "tag": "170x128"
            }
          ]
        },
        "provider": {
          "displayName": "Insider Monkey",
          "url": "http://www.insidermonkey.com"
        },
        "canonicalUrl": {
          "url": "https://finance.yahoo.com/news/jim-cramer-says-eli-lilly-122408617.html",
          "site": "finance",
          "region": "US",
          "lang": "en-US"
        },
        "clickThroughUrl": {
          "url": "https://finance.yahoo.com/news/jim-cramer-says-eli-lilly-122408617.html",
          "site": "finance",
          "region": "US",
          "lang": "en-US"
        },
        "metadata": {
          "editorsPick": false
        },
        "finance": {
          "stockTickers": [
            {
              "symbol": "LLY"
            },
            {
              "symbol": "AVGO"
            },
            {
              "symbol": "AMD"
            },
            {
              "symbol": "NVDA"
            }
          ],
          "premiumFinance": {
            "isPremiumNews": false,
            "isPremiumFreeNews": false
          }
        },
        "storyline": null
      }
    }
  },
  {
    "ts": "2026-02-03T13:55:00+00:00",
    "headline": "NYSE Content Advisory: Pre-Market Update + AstraZeneca Climbs Nearly 1% After Historic NYSE Transfer",
    "summary": "The New York Stock Exchange (NYSE) provides a daily pre-market update directly from the NYSE Trading Floor. Access today's NYSE Pre-market update for market insights before trading begins.",
    "url": "https://finance.yahoo.com/news/nyse-content-advisory-pre-market-135500762.html",
    "source": "PR Newswire",
    "provider": "yfinance",
    "raw": {
      "id": "b1d67566-0399-343c-ac50-99014359b27c",
      "content": {
        "id": "b1d67566-0399-343c-ac50-99014359b27c",
        "contentType": "STORY",
        "title": "NYSE Content Advisory: Pre-Market Update + AstraZeneca Climbs Nearly 1% After Historic NYSE Transfer",
        "description": "",
        "summary": "The New York Stock Exchange (NYSE) provides a daily pre-market update directly from the NYSE Trading Floor. Access today's NYSE Pre-market update for market insights before trading begins.",
        "pubDate": "2026-02-03T13:55:00Z",
        "displayTime": "2026-02-03T13:55:00Z",
        "isHosted": true,
        "bypassModal": false,
        "previewUrl": null,
        "thumbnail": {
          "originalUrl": "https://media.zenfs.com/en/prnewswire.com/f985d06f2b5969eaa00290f59703453f",
          "originalWidth": 400,
          "originalHeight": 208,
          "caption": "NYSE Logo",
          "resolutions": [
            {
              "url": "https://s.yimg.com/uu/api/res/1.2/kVXnG4ZXSpuGNWLqSSsPaA--~B/aD0yMDg7dz00MDA7YXBwaWQ9eXRhY2h5b24-/https://media.zenfs.com/en/prnewswire.com/f985d06f2b5969eaa00290f59703453f.cf.webp",
              "width": 400,
              "height": 208,
              "tag": "original"
            },
            {
              "url": "https://s.yimg.com/uu/api/res/1.2/Iv_eqik8iTDqCNAZ4IYLxQ--~B/Zmk9c3RyaW07aD0xMjg7dz0xNzA7YXBwaWQ9eXRhY2h5b24-/https://media.zenfs.com/en/prnewswire.com/f985d06f2b5969eaa00290f59703453f.cf.webp",
              "width": 170,
              "height": 128,
              "tag": "170x128"
            }
          ]
        },
        "provider": {
          "displayName": "PR Newswire",
          "url": "https://www.prnewswire.com/"
        },
        "canonicalUrl": {
          "url": "https://finance.yahoo.com/news/nyse-content-advisory-pre-market-135500762.html",
          "site": "finance",
          "region": "US",
          "lang": "en-US"
        },
        "clickThroughUrl": {
          "url": "https://finance.yahoo.com/news/nyse-content-advisory-pre-market-135500762.html",
          "site": "finance",
          "region": "US",
          "lang": "en-US"
        },
        "metadata": {
          "editorsPick": false
        },
        "finance": {
          "stockTickers": [
            {
              "symbol": "AZN"
            },
            {
              "symbol": "ICE"
            },
            {
              "symbol": "TYL"
            },
            {
              "symbol": "ORCL"
            },
            {
              "symbol": "PFE"
            },
            {
              "symbol": "UBER"
            },
            {
              "symbol": "LLY"
            }
          ],
          "premiumFinance": {
            "isPremiumNews": false,
            "isPremiumFreeNews": false
          }
        },
        "storyline": null
      }
    }
  },
  {
    "ts": "2026-02-03T13:00:00+00:00",
    "headline": "Zonsen PepLib Biotech Enters Global R&D Collaboration and License Agreement with Lilly",
    "summary": "ZHUZHOU, China, February 03, 2026--Zonsen PepLib Biotech Inc. (\"PepLib\") today announced that it has entered a global research and development (R&D) collaboration and license agreement with Eli Lilly and Company (\"Lilly\"). Under the agreement, both parties will jointly advance the development of novel peptide-based drug candidates leveraging PepLib’s robust and diverse proprietary peptide libraries and discovery technology platforms.",
    "url": "https://finance.yahoo.com/news/zonsen-peplib-biotech-enters-global-130000598.html",
    "source": "Business Wire",
    "provider": "yfinance",
    "raw": {
      "id": "3e72bbce-23e3-3faf-ac8c-4937ac4fa035",
      "content": {
        "id": "3e72bbce-23e3-3faf-ac8c-4937ac4fa035",
        "contentType": "STORY",
        "title": "Zonsen PepLib Biotech Enters Global R&D Collaboration and License Agreement with Lilly",
        "description": "",
        "summary": "ZHUZHOU, China, February 03, 2026--Zonsen PepLib Biotech Inc. (\"PepLib\") today announced that it has entered a global research and development (R&D) collaboration and license agreement with Eli Lilly and Company (\"Lilly\"). Under the agreement, both parties will jointly advance the development of novel peptide-based drug candidates leveraging PepLib’s robust and diverse proprietary peptide libraries and discovery technology platforms.",
        "pubDate": "2026-02-03T13:00:00Z",
        "displayTime": "2026-02-03T13:00:00Z",
        "isHosted": true,
        "bypassModal": false,
        "previewUrl": null,
        "thumbnail": {
          "originalUrl": "https://media.zenfs.com/en/business-wire.com/2e3c4fea4f23d5c4bd8de4870375de0a",
          "originalWidth": 1024,
          "originalHeight": 512,
          "caption": "",
          "resolutions": [
            {
              "url": "https://s.yimg.com/uu/api/res/1.2/vKCBqlpxEjniSxILCwsX8w--~B/aD01MTI7dz0xMDI0O2FwcGlkPXl0YWNoeW9u/https://media.zenfs.com/en/business-wire.com/2e3c4fea4f23d5c4bd8de4870375de0a.cf.webp",
              "width": 1024,
              "height": 512,
              "tag": "original"
            },
            {
              "url": "https://s.yimg.com/uu/api/res/1.2/TtKJx4iE45TRFwzQmP9Q5A--~B/Zmk9c3RyaW07aD0xMjg7dz0xNzA7YXBwaWQ9eXRhY2h5b24-/https://media.zenfs.com/en/business-wire.com/2e3c4fea4f23d5c4bd8de4870375de0a.cf.webp",
              "width": 170,
              "height": 128,
              "tag": "170x128"
            }
          ]
        },
        "provider": {
          "displayName": "Business Wire",
          "url": "http://www.businesswire.com/"
        },
        "canonicalUrl": {
          "url": "https://finance.yahoo.com/news/zonsen-peplib-biotech-enters-global-130000598.html",
          "site": "finance",
          "region": "US",
          "lang": "en-US"
        },
        "clickThroughUrl": {
          "url": "https://finance.yahoo.com/news/zonsen-peplib-biotech-enters-global-130000598.html",
          "site": "finance",
          "region": "US",
          "lang": "en-US"
        },
        "metadata": {
          "editorsPick": false
        },
        "finance": {
          "stockTickers": [
            {
              "symbol": "LLY"
            }
          ],
          "premiumFinance": {
            "isPremiumNews": false,
            "isPremiumFreeNews": false
          }
        },
        "storyline": null
      }
    }
  },
  {
    "ts": "2026-02-03T12:40:02+00:00",
    "headline": "Merck (MRK) Q4 Earnings and Revenues Beat Estimates",
    "summary": "Merck (MRK) delivered earnings and revenue surprises of +0.62% and +1.33%, respectively, for the quarter ended December 2025. Do the numbers hold clues to what lies ahead for the stock?",
    "url": "https://finance.yahoo.com/news/merck-mrk-q4-earnings-revenues-124002891.html",
    "source": "Zacks",
    "provider": "yfinance",
    "raw": {
      "id": "a7b30f57-5615-3055-b616-4bbe5ca80847",
      "content": {
        "id": "a7b30f57-5615-3055-b616-4bbe5ca80847",
        "contentType": "STORY",
        "title": "Merck (MRK) Q4 Earnings and Revenues Beat Estimates",
        "description": "",
        "summary": "Merck (MRK) delivered earnings and revenue surprises of +0.62% and +1.33%, respectively, for the quarter ended December 2025. Do the numbers hold clues to what lies ahead for the stock?",
        "pubDate": "2026-02-03T12:40:02Z",
        "displayTime": "2026-02-03T12:40:02Z",
        "isHosted": true,
        "bypassModal": false,
        "previewUrl": null,
        "thumbnail": {
          "originalUrl": "https://media.zenfs.com/en/zacks.com/b9775f315e7b6c4ada6e36d0048a929a",
          "originalWidth": 900,
          "originalHeight": 728,
          "caption": "",
          "resolutions": [
            {
              "url": "https://s.yimg.com/uu/api/res/1.2/qda7CGFBlQ8XGALeSrKgqg--~B/aD03Mjg7dz05MDA7YXBwaWQ9eXRhY2h5b24-/https://media.zenfs.com/en/zacks.com/b9775f315e7b6c4ada6e36d0048a929a.cf.webp",
              "width": 900,
              "height": 728,
              "tag": "original"
            },
            {
              "url": "https://s.yimg.com/uu/api/res/1.2/4xjRGdTikgXo5SMeFUiNTA--~B/Zmk9c3RyaW07aD0xMjg7dz0xNzA7YXBwaWQ9eXRhY2h5b24-/https://media.zenfs.com/en/zacks.com/b9775f315e7b6c4ada6e36d0048a929a.cf.webp",
              "width": 170,
              "height": 128,
              "tag": "170x128"
            }
          ]
        },
        "provider": {
          "displayName": "Zacks",
          "url": "http://www.zacks.com/"
        },
        "canonicalUrl": {
          "url": "https://finance.yahoo.com/news/merck-mrk-q4-earnings-revenues-124002891.html",
          "site": "finance",
          "region": "US",
          "lang": "en-US"
        },
        "clickThroughUrl": {
          "url": "https://finance.yahoo.com/news/merck-mrk-q4-earnings-revenues-124002891.html",
          "site": "finance",
          "region": "US",
          "lang": "en-US"
        },
        "metadata": {
          "editorsPick": false
        },
        "finance": {
          "stockTickers": [
            {
              "symbol": "MRK"
            },
            {
              "symbol": "LLY"
            }
          ],
          "premiumFinance": {
            "isPremiumNews": false,
            "isPremiumFreeNews": false
          }
        },
        "storyline": null
      }
    }
  },
  {
    "ts": "2026-02-03T15:09:05+00:00",
    "headline": "Eli Lilly Expands Weight Loss And Pipeline Bets As Valuation Draws Focus",
    "summary": "Eli Lilly (NYSE:LLY) is committing $3.5b to a new Pennsylvania manufacturing facility for next generation injectable weight loss therapies. The company has entered a gene editing collaboration with Seamless Therapeutics targeting certain forms of hearing loss. Lilly also announced a partnership with Repertoire Immune Medicines focused on autoimmune disease therapies. Eli Lilly comes into these moves with its share price at $1,044.13 and a 1 year return of 29.8%. Over 3 years, the stock is...",
    "url": "https://finance.yahoo.com/news/eli-lilly-expands-weight-loss-150905628.html",
    "source": "Simply Wall St.",
    "provider": "yfinance",
    "raw": {
      "id": "a8103209-e1e2-3989-b480-9dd7eff0b716",
      "content": {
        "id": "a8103209-e1e2-3989-b480-9dd7eff0b716",
        "contentType": "STORY",
        "title": "Eli Lilly Expands Weight Loss And Pipeline Bets As Valuation Draws Focus",
        "description": "",
        "summary": "Eli Lilly (NYSE:LLY) is committing $3.5b to a new Pennsylvania manufacturing facility for next generation injectable weight loss therapies. The company has entered a gene editing collaboration with Seamless Therapeutics targeting certain forms of hearing loss. Lilly also announced a partnership with Repertoire Immune Medicines focused on autoimmune disease therapies. Eli Lilly comes into these moves with its share price at $1,044.13 and a 1 year return of 29.8%. Over 3 years, the stock is...",
        "pubDate": "2026-02-03T15:09:05Z",
        "displayTime": "2026-02-03T15:09:05Z",
        "isHosted": true,
        "bypassModal": false,
        "previewUrl": null,
        "thumbnail": {
          "originalUrl": "https://media.zenfs.com/en/simply_wall_st__316/5eef176f2a2dc130a63fafe4bd1968dd",
          "originalWidth": 1194,
          "originalHeight": 432,
          "caption": "",
          "resolutions": [
            {
              "url": "https://s.yimg.com/uu/api/res/1.2/uZWvuDuy6_Wr6cKvxAFZcw--~B/aD00MzI7dz0xMTk0O2FwcGlkPXl0YWNoeW9u/https://media.zenfs.com/en/simply_wall_st__316/5eef176f2a2dc130a63fafe4bd1968dd.cf.webp",
              "width": 1194,
              "height": 432,
              "tag": "original"
            },
            {
              "url": "https://s.yimg.com/uu/api/res/1.2/g78F5NO5pySOmBHzFi6.eA--~B/Zmk9c3RyaW07aD0xMjg7dz0xNzA7YXBwaWQ9eXRhY2h5b24-/https://media.zenfs.com/en/simply_wall_st__316/5eef176f2a2dc130a63fafe4bd1968dd.cf.webp",
              "width": 170,
              "height": 128,
              "tag": "170x128"
            }
          ]
        },
        "provider": {
          "displayName": "Simply Wall St.",
          "url": "https://simplywall.st/"
        },
        "canonicalUrl": {
          "url": "https://finance.yahoo.com/news/eli-lilly-expands-weight-loss-150905628.html",
          "site": "finance",
          "region": "US",
          "lang": "en-US"
        },
        "clickThroughUrl": {
          "url": "https://finance.yahoo.com/news/eli-lilly-expands-weight-loss-150905628.html",
          "site": "finance",
          "region": "US",
          "lang": "en-US"
        },
        "metadata": {
          "editorsPick": false
        },
        "finance": {
          "stockTickers": [
            {
              "symbol": "LLY"
            }
          ],
          "premiumFinance": {
            "isPremiumNews": false,
            "isPremiumFreeNews": false
          }
        },
        "storyline": null
      }
    }
  },
  {
    "ts": "2026-02-03T14:59:39+00:00",
    "headline": "Pfizer Targets Monthly Obesity Shot. Why Lilly Could Still Have The Weight-Loss Heavyweight.",
    "summary": "An analyst says Eli Lilly's Zepbound still looks like the heavyweight in weight loss compared to Pfizer's injection.",
    "url": "https://www.investors.com/news/technology/pfizer-stock-pfizer-earnings-q4-2025/?src=A00220&yptr=yahoo",
    "source": "Investor's Business Daily",
    "provider": "yfinance",
    "raw": {
      "id": "a6690680-4744-39b6-b573-92ec5198f33f",
      "content": {
        "id": "a6690680-4744-39b6-b573-92ec5198f33f",
        "contentType": "STORY",
        "title": "Pfizer Targets Monthly Obesity Shot. Why Lilly Could Still Have The Weight-Loss Heavyweight.",
        "description": "",
        "summary": "An analyst says Eli Lilly's Zepbound still looks like the heavyweight in weight loss compared to Pfizer's injection.",
        "pubDate": "2026-02-03T14:59:39Z",
        "displayTime": "2026-02-03T14:59:39Z",
        "isHosted": false,
        "bypassModal": false,
        "previewUrl": "https://finance.yahoo.com/m/a6690680-4744-39b6-b573-92ec5198f33f/pfizer-targets-monthly.html",
        "thumbnail": {
          "originalUrl": "https://media.zenfs.com/en/ibd.com/3dffc435f585895e4f9c02c947878503",
          "originalWidth": 1000,
          "originalHeight": 563,
          "caption": "",
          "resolutions": [
            {
              "url": "https://s.yimg.com/uu/api/res/1.2/JiB.MKe4.kKoFP7tJVVVFA--~B/aD01NjM7dz0xMDAwO2FwcGlkPXl0YWNoeW9u/https://media.zenfs.com/en/ibd.com/3dffc435f585895e4f9c02c947878503.cf.webp",
              "width": 1000,
              "height": 563,
              "tag": "original"
            },
            {
              "url": "https://s.yimg.com/uu/api/res/1.2/ReA03i3fOiLRtVTA7uA7gg--~B/Zmk9c3RyaW07aD0xMjg7dz0xNzA7YXBwaWQ9eXRhY2h5b24-/https://media.zenfs.com/en/ibd.com/3dffc435f585895e4f9c02c947878503.cf.webp",
              "width": 170,
              "height": 128,
              "tag": "170x128"
            }
          ]
        },
        "provider": {
          "displayName": "Investor's Business Daily",
          "url": "http://www.investors.com/"
        },
        "canonicalUrl": {
          "url": "https://www.investors.com/news/technology/pfizer-stock-pfizer-earnings-q4-2025/?src=A00220&yptr=yahoo",
          "site": "finance",
          "region": "US",
          "lang": "en-US"
        },
        "clickThroughUrl": null,
        "metadata": {
          "editorsPick": false
        },
        "finance": {
          "stockTickers": [
            {
              "symbol": "LLY"
            },
            {
              "symbol": "PFE"
            }
          ],
          "premiumFinance": {
            "isPremiumNews": false,
            "isPremiumFreeNews": false
          }
        },
        "storyline": null
      }
    }
  },
  {
    "ts": "2026-02-03T13:55:00+00:00",
    "headline": "NYSE Content Advisory: Pre-Market Update + AstraZeneca Climbs Nearly 1% After Historic NYSE Transfer",
    "summary": "The New York Stock Exchange (NYSE) provides a daily pre-market update directly from the NYSE Trading Floor. Access today's NYSE Pre-market update for market insights before trading begins.",
    "url": "https://finance.yahoo.com/news/nyse-content-advisory-pre-market-135500825.html",
    "source": "PR Newswire",
    "provider": "yfinance",
    "raw": {
      "id": "2abced3f-1359-3da0-8489-bb1d628b8c89",
      "content": {
        "id": "2abced3f-1359-3da0-8489-bb1d628b8c89",
        "contentType": "STORY",
        "title": "NYSE Content Advisory: Pre-Market Update + AstraZeneca Climbs Nearly 1% After Historic NYSE Transfer",
        "description": "",
        "summary": "The New York Stock Exchange (NYSE) provides a daily pre-market update directly from the NYSE Trading Floor. Access today's NYSE Pre-market update for market insights before trading begins.",
        "pubDate": "2026-02-03T13:55:00Z",
        "displayTime": "2026-02-03T13:55:00Z",
        "isHosted": true,
        "bypassModal": false,
        "previewUrl": null,
        "thumbnail": {
          "originalUrl": "https://media.zenfs.com/en/prnewswire.com/b9671ae7464553162e92a9c647b76a24",
          "originalWidth": 400,
          "originalHeight": 208,
          "caption": "NYSE Logo (PRNewsfoto/New York Stock Exchange)",
          "resolutions": [
            {
              "url": "https://s.yimg.com/uu/api/res/1.2/eICwDWA7RQRDoiLnMVVbRQ--~B/aD0yMDg7dz00MDA7YXBwaWQ9eXRhY2h5b24-/https://media.zenfs.com/en/prnewswire.com/b9671ae7464553162e92a9c647b76a24.cf.webp",
              "width": 400,
              "height": 208,
              "tag": "original"
            },
            {
              "url": "https://s.yimg.com/uu/api/res/1.2/A9Dsiv4zcIgtd9IYTHmayA--~B/Zmk9c3RyaW07aD0xMjg7dz0xNzA7YXBwaWQ9eXRhY2h5b24-/https://media.zenfs.com/en/prnewswire.com/b9671ae7464553162e92a9c647b76a24.cf.webp",
              "width": 170,
              "height": 128,
              "tag": "170x128"
            }
          ]
        },
        "provider": {
          "displayName": "PR Newswire",
          "url": "https://www.prnewswire.com/"
        },
        "canonicalUrl": {
          "url": "https://finance.yahoo.com/news/nyse-content-advisory-pre-market-135500825.html",
          "site": "finance",
          "region": "US",
          "lang": "en-US"
        },
        "clickThroughUrl": {
          "url": "https://finance.yahoo.com/news/nyse-content-advisory-pre-market-135500825.html",
          "site": "finance",
          "region": "US",
          "lang": "en-US"
        },
        "metadata": {
          "editorsPick": false
        },
        "finance": {
          "stockTickers": [
            {
              "symbol": "AZN"
            },
            {
              "symbol": "ICE"
            },
            {
              "symbol": "TYL"
            },
            {
              "symbol": "ORCL"
            },
            {
              "symbol": "PFE"
            },
            {
              "symbol": "UBER"
            },
            {
              "symbol": "LLY"
            }
          ],
          "premiumFinance": {
            "isPremiumNews": false,
            "isPremiumFreeNews": false
          }
        },
        "storyline": null
      }
    }
  }
]